SEC Form 4 · accession 0001161697-18-000038
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David S Tierney
Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $4.01 | Jan 2, 2018 | A | 20,000 | A | Jan 2, 2018 | Jan 2, 2025 | Common Stock | 20,000 | 220,000 | D |
| Options to purchase common stock | $4.01 | Jan 2, 2018 | A | 20,000 | A | Jan 2, 2019 | Jan 2, 2025 | Common Stock | 20,000 | 240,000 | D |